Ablation for Atrial Fibrillation Combined with Left Atrial Appendage Closure

JACC: Clinical Electrophysiology

Volumn 1, Issue 6, 2015, Pages 486-495

  Alipour, Arash ^a   Swaans, Martin J ^a   Van Dijk, Vincent F ^a   Balt, Jippe C ^a   Post, Martijn C ^a   Bosschaert, Mike A R ^a   Rensing, Benno J ^a   Reddy, Vivek Y ^b   Boersma, Lucas V A ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; left atrial appendage closure; stroke

Indexed keywords

ABLATION CATHETER; ABLATION THERAPY; ADULT; ANTICOAGULATION; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CARDIOVERSION; CAROTID ARTERY; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; FALL RISK; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; LEFT ATRIAL APPENDAGE OCCLUSION; LEFT VENTRICULAR APEX; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCLUSION; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 84952051533     PISSN: 2405500X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacep.2015.07.009     Document Type: Article

References (43)

1. A.J. Camm, G.Y. Lip, R. De Caterina, et al. ESC Committee for Practice Guidelines (CPG) 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association Europace 14 2012 1385 1413
2. A.S. Go, E.M. Hylek, K.A. Phillips, and et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 2001 2370 2375
3. S. Stewart, C.L. Hart, D.J. Hole, and J.J. McMurray Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study Heart 86 2001 516 521
4. I.C. Van Gelder, V.E. Hagens, H.A. Bosker, and et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation N Engl J Med 347 2002 1834 1840
5. D.G. Wyse, A.L. Waldo, J.P. DiMarco, et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833
6. L.M. Haegeli, and H. Calkins Catheter ablation of atrial fibrillation: an update Eur Heart J 35 2014 2454 2459
7. O. De Backer, S. Arnous, N. Ihlemann, and et al. Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update Open Heart 1 2014 e000020
8. J.W. Eikelboom, L. Wallentin, S.J. Connolly, and et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger pts with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial Circulation 123 2011 2363 2372
9. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly pts with atrial fibrillation Circulation 115 2007 2689 2696
10. M. Sudlow, R. Thomson, B. Thwaites, H. Rodgers, and R.A. Kenny Prevalence of atrial fibrillation and eligibility for anticoagulants in the community Lancet 352 1998 1167 1171
11. L. Wallentin, S. Yusuf, M.D. Ezekowitz, and et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial Lancet 376 2010 975 983
12. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, et al. RE-LY Steering Committee and Investigators Dabigatran versus warfarin in pts with atrial fibrillation N Engl J Med 361 2009 1139 1151
13. M.R. Patel, K.W. Mahaffey, J. Garg, et al. ROCKET AF Investigators Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
14. C.B. Granger, J.H. Alexander, J.J. McMurray, et al. ARISTOTLE Committees and Investigators Apixaban versus warfarin in pts with atrial fibrillation N Engl J Med 365 2011 981 992
15. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical pts with atrial fibrillation Ann Thorac Surg 61 1996 755 759
16. V.Y. Reddy, S.K. Doshi, H. Sievert, et al. PROTECT AF Investigators Percutaneous left atrial appendage closure for stroke prophylaxis in pts with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Pts with Atrial Fibrillation) Trial Circulation 127 2013 720 729
17. D.R. Holmes Jr., S. Kar, M.J. Price, and et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in pts with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial J Am Coll Cardiol 64 2014 1 12
18. V.Y. Reddy, H. Sievert, J. Halperin, et al. PROTECT AF Steering Committee and Investigators Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial JAMA 312 2014 1988 1998
19. V.Y. Reddy, S. Möbius-Winkler, M.A. Miller, and et al. Left atrial appendage closure with the Watchman device in pts with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol 61 2013 2551 2556
20. M.J. Swaans, M.C. Post, B.J. Rensing, and L.V. Boersma Ablation for atrial fibrillation in combination with left atrial appendage closure: first results of a feasibility study J Am Heart Assoc 1 2012 e002212
21. A.A. Mulder, J.C. Balt, M.C. Wijffels, E.F. Wever, and L.V. Boersma Safety of pulmonary vein isolation and left atrial complex fractionated atrial electrograms ablation for atrial fibrillation with phased radiofrequency energy and multi-electrode catheters Europace 14 2012 1433 1440
22. L.V. Boersma, M.C. Wijffels, H. Oral, E.F. Wever, and F. Morady Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielec-trode ablation catheter Heart Rhythm 5 2008 1635 1642
23. A.A. Mulder, M.C. Wijffels, E.F. Wever, and L.V. Boersma Pulmonary vein isolation and left atrial complex-fractionated atrial electrograms ablation for persistent atrial fibrillation with phased radio frequency energy and multi-electrode catheters: efficacy and safety during 12 months follow-up Europace 12 2011 1695 1702
24. R.B. Fountain, D.R. Holmes, K. Chandrasekaran, and et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Pts with Atrial Fibrillation) trial Am Heart J 151 2006 956 961
25. D.R. Holmes, V.Y. Reddy, Z.G. Turi, and et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in pts with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
26. H. Oral, A. Chugh, M. Ozaydin, and et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation Circulation 114 2006 759 765
27. S.R. Gangireddy, J.L. Halperin, V. Fuster, and V.Y. Reddy Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit Eur Heart J 33 2012 2700 2708
28. L.V. Boersma, M. Castella, W. van Boven, and et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial Circulation 125 2012 23 30
29. A.G. Brooks, M.K. Stiles, J. Laborderie, and et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review Heart Rhythm 7 2010 835 846
30. F. Ouyang, R. Tilz, J. Chun, and et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up Circulation 122 2010 2368 2377
31. R. Weerasooriya, P. Khairy, J. Litalien, and et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 57 2011 160 166
32. J. Buber, D. Luria, L. Sternik, and et al. Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke J Am Coll Cardiol 58 2011 1614 1621
33. L. Di Biase, J.D. Burkhardt, P. Mohanty, and et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation Circulation 122 2010 109 118
34. M.R. Afzal, A. Kanmanthareddy, M. Earnest, and et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices Heart Rhythm 12 2015 52 59
35. J. Pillarisetti, Y.M. Reddy, S. Gunda, and et al. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications Heart Rhythm 12 2015 1501 1507
36. S. Chatterjee, H.C. Herrmann, R.L. Wilensky, and et al. Safety and procedural success of left atrial appendage exclusion with the Lariat device: a systematic review of published reports and analytic review of the FDA MAUDE database JAMA Intern Med 175 2015 1104 1109
37. O. Onalan, and E. Crystal Left atrial appendage exclusion for stroke prevention in pts with nonrheumatic atrial fibrillation Stroke 38 2007 624 630
38. R.P. Whitlock, J.S. Healey, and S.J. Connolly Left atrial appendage occlusion does not eliminate the need for warfarin Circulation 120 2009 1927 1932
39. J.F. Viles-Gonzalez, S. Kar, P. Douglas, and et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in pts with atrial fibrillation: a PROTECT AF Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Pts With Atrial Fibrillation) substudy J Am Coll Cardiol 59 2012 923 929
40. C. Herrera Siklódy, T. Deneke, M. Hocini, and et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study J Am Coll Cardiol 58 2011 681 688
41. F. Gaita, J.F. Leclercq, B. Schumacher, and et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon J Cardiovasc Electrophysiol 22 2011 961 968
42. D.E. Haines, M.T. Stewart, S. Dahlberg, and et al. Microembolism and catheter ablation I: a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia Circ Arrhythm Electrophysiol 6 2013 16 22
43. A. Verma, P. Debruyne, S. Nardi, and et al. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial Circ Arrhythm Electrophysiol 6 2013 835 842